Inokuchi K, Mori H, Matsuzaki J, Hirata K, et al. Efficacy and safety of low-dose rifabutin-based 7-day triple therapy as a third- or later-line Helicobacter pylori eradication regimen. Helicobacter 2022 May 29:e12900. doi: 10.1111/hel.12900.
PMID: 35644041